BridgeBio Pharma

BridgeBio Pharma

Associate Director, KOL Engagement (Achondroplasia)

Remote - USA · Director · Full-time

Sponsorship not specified$30k-$40kDetected 12 days ago
A/B TestingProject ManagementBrand StrategyResearchLeadershipCommunicationCollaboration

About the role

  • Patient Champions, who put patients first and uphold strict ethical standards
  • Truth Seekers, who are detailed, rational, and humble problem solvers
  • Individuals Who Inspire Excellence in themselves and those around them

Responsibilities

  • Design KOL identification/profiling, mapping and key strategic efforts to establish engagement with and by KOLs in the achondroplasia, skeletal dysplasia or bone development space
  • Lead the creation, execution and maintenance of the commercial Key Opinion Leader engagement plan to build, cultivate and maintain KOL relationships
  • Develop resources for KOL engagement activities such as a database or similar platform for tracking of KOL partnership
  • Support development and management of the infigratinib speaker bureau, including program design, ongoing maintenance, speaker selection, and innovative strategies to strengthen brand messaging
  • Lead US Congress KOL engagement planning for the commercial team
  • Lead the development and execution of commercial advisory boards to inform, uncover opportunities and support brand strategy and launch preparation
  • Developing targeted measurement plans - setting goals and meeting KPIs
  • Work cross-functionally with agency partners, sales, commercial operations, brand analytics, IT, MCM, etc.

Requirements

  • The role requires strong clinical acumen, communication and leadership skills, and the ability to influence across the organization.
  • Experience leading KOL engagement activities, including the management of KOL data and implementation of strategic initiatives
  • High-level strategic thinking, with the ability to translate customer insights into actionable marketing strategy and to align with key stakeholders on operational priorities

Nice to have

  • Field-based experience and/or leadership is strongly preferred but not required
  • Achondroplasia experience strongly preferred
  • Successful launch experience in a competitive market preferred

Skills

  • Excellent oral, written, and presentation skills

Compensation

  • $175,900 - $222,000 USD
  • Market-leading compensation

Benefits

  • Liaise and communicate with internal stakeholders, including medical affairs and product development, advisory board insights to ensure aligned understanding and implementation
  • Entrepreneurial Operators, who drive towards practical solutions and have an ownership mindset
  • Employee Stock Purchase Program (ESPP)
  • As a global company, our comprehensive benefits may vary based on location.

Company info

  • Partner closely with internal teams to ensure we are using appropriate insights and metrics to inform the KOL management strategy and activities - directly to KOLs and with KOLs toward community physicians

This listing is sourced directly from BridgeBio Pharma's careers page and normalized into a canonical job model.